Sponsor Pipeline

Chen Lizhu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07638631 Ipilimumab (N01) Plus Sintilimab and Modified XELOX as Conversion Therapy in Unresectable… Locally Advanced Gastric Cancer Not Yet Recruiting
Disease Areas
Get alerts when Chen Lizhu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free